News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

Correspondence: Lipoid GmbH, Frigenstraße 4, D-67065 Ludwigshafen, Germany, Tel: +49 621 53819 301, p.hoelig@lipoid.com

Articles by Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

Phospholipids in Pharmaceutical Form Line Extensions

ByPeter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany,Peter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

October 1st 2022

Synthetic Phospholipids as Excipients for Parenteral and Pulmonary Administration

ByPeter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany,Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany

September 22nd 2021

Latest Updated Articles

Trending on Pharmaceutical Technology

FDA Approval of Cytokinetics’ Myqorzo Reflects Specialty Cardio Drug Trend

How Codexis is Redefining Pharma Biocatalysis

Innovation and Market Exclusivity in the EU

FAQ: Sustainability in Pharma

How Codexis is Transforming RNA Manufacturing